Clinical Trial

A Study of CAR-T Cells in Subjects With Autoimmune Diseases

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with autoimmune diseases.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-18.
Trial Details
NCT Number NCT07040917
Lead Sponsor Chinese PLA General Hospital
Conditions Autoimmune Diseases
Enrollment 12 participants
Start Date 2025-09-30
Primary Completion 2027-11-30 (estimated)
Study Completion 2028-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-20